Laboratory Corporation of America Holdings (LH): Price and Financial Metrics


Laboratory Corporation of America Holdings (LH)

Today's Latest Price: $180.12 USD

0.30 (0.17%)

Updated Jun 3 2:49pm

Add LH to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

LH Stock Summary

  • LH has a market capitalization of $17,478,504,000 -- more than approximately 90.15% of US stocks.
  • With a price/earnings ratio of 54.45, Laboratory Corp Of America Holdings P/E ratio is greater than that of about 87.13% of stocks in our set with positive earnings.
  • The volatility of Laboratory Corp Of America Holdings's share price is greater than that of merely 12.94% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to LH, based on their financial statements, market capitalization, and price volatility, are NDAQ, TRU, SJM, IP, and EFX.
  • LH's SEC filings can be seen here. And to visit Laboratory Corp Of America Holdings's official web site, go to www.labcorp.com.
LH Daily Price Range
LH 52-Week Price Range

LH Stock Price Chart More Charts


LH Price/Volume Stats

Current price $180.12 52-week high $196.36
Prev. close $179.82 52-week low $98.02
Day low $179.11 Volume 317,661
Day high $183.17 Avg. volume 1,053,436
50-day MA $154.04 Dividend yield N/A
200-day MA $165.86 Market Cap 17.51B

Laboratory Corporation of America Holdings (LH) Company Bio


Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analysis, urinalysis, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases. The company was founded in 1971 and is based in Burlington, North Carolina.

LH Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$180.12$181.834%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Laboratory Corp Of America Holdings. To summarize, we found that Laboratory Corp Of America Holdings ranked in the 48th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for Laboratory Corp Of America Holdings ended up being:

  • The company's balance sheet shows it gets 71% of its capital from equity, and 29% of its capital from debt. Notably, its equity weight is greater than just 24.63% of US equities in the Healthcare sector yielding a positive free cash flow.
  • Laboratory Corp Of America Holdings's weighted average cost of capital (WACC) is 7%; for context, that number is higher than merely 17.52% of tickers in our DCF set.
  • Laboratory Corp Of America Holdings's effective tax rate, as measured by taxes paid relative to net income, is at 24 -- greater than 86.79% of US stocks with positive free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%2%
1%3%
2%4%
3%5%
4%6%
5%7%

Want more companies with a valuation profile/forecast similar to that of Laboratory Corp Of America Holdings? See ACIU, HCSG, HSIC, EDAP, and GILD.


LH Latest News Stream


Event/TimeNews Detail
Loading, please wait...

LH Latest Social Stream


Loading social stream, please wait...

View Full LH Social Stream

Latest LH News From Around the Web

Below are the latest news stories about Laboratory Corp Of America Holdings that investors may wish to consider to help them evaluate LH as an investment opportunity.

Surging Earnings Estimates Signal Upside for LabCorp (LH) Stock

LabCorp (LH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Yahoo | June 2, 2020

LH vs. ALGN: Which Stock Should Value Investors Buy Now?

LH vs. ALGN: Which Stock Is the Better Value Option?

Yahoo | June 2, 2020

LabCorp Launches New COVID-19 Clinical Trial Site to Connect Patients With U.S. Research Trials

LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, has created COVID-19 Clinical Trial Connect in the U.S., a site designed to help people access information about how to participate in COVID-19 research.

Yahoo | June 1, 2020

Laboratory Corp. of America Holdings (LH): Are Hedge Funds Right About This Stock?

In this article we will check out the progression of hedge fund sentiment towards Laboratory Corp. of America Holdings (NYSE:LH) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their […]

Yahoo | May 29, 2020

LabCorp (LH) Up 6.8% Since Last Earnings Report: Can It Continue?

LabCorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | May 29, 2020

Read More 'LH' Stories Here

LH Price Returns

1-mo 14.25%
3-mo -3.69%
6-mo 4.92%
1-year 8.23%
3-year 27.22%
5-year 50.92%
YTD 6.47%
2019 33.88%
2018 -20.78%
2017 24.25%
2016 3.83%
2015 14.59%

Continue Researching LH

Here are a few links from around the web to help you further your research on Laboratory Corp Of America Holdings's stock as an investment opportunity:

Laboratory Corp Of America Holdings (LH) Stock Price | Nasdaq
Laboratory Corp Of America Holdings (LH) Stock Quote, History and News - Yahoo Finance
Laboratory Corp Of America Holdings (LH) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8794 seconds.